For: | Hong S, Song KB, Hwang DW, Lee JH, Lee W, Jun E, Kwon J, Park Y, Park SY, Kim N, Shin D, Kim H, Sung M, Ryu Y, Kim SC. Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma. World J Gastrointest Surg 2021; 13(11): 1423-1435 [PMID: 34950431 DOI: 10.4240/wjgs.v13.i11.1423] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v13/i11/1423.htm |
Number | Citing Articles |
1 |
Taichi Terai, Minako Nagai, Kota Nakamura, Yuichiro Kohara, Satoshi Yasuda, Yasuko Matsuo, Shunsuke Doi, Takeshi Sakata, Masayuki Sho. Combination of carbohydrate antigen 19-9 level and tumor size after neoadjuvant chemoradiation therapy may predict early recurrence of resectable pancreatic ductal adenocarcinoma. Pancreatology 2023; 23(8): 970 doi: 10.1016/j.pan.2023.10.014
|
2 |
Yuan Zhou, Maoen Pan, Ronggui Lin, Heguang Huang. Advances in hydrogel materials applied to pancreatic-related diseases. Journal of Pancreatology 2024; 7(3): 222 doi: 10.1097/JP9.0000000000000158
|
3 |
Zhenshan Shi, Chengle Ma, Xinming Huang, Dairong Cao. Magnetic Resonance Imaging Radiomics‐Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study. Journal of Magnetic Resonance Imaging 2022; 55(3): 823 doi: 10.1002/jmri.28048
|
4 |
Jingjing Li, Jiadi Du, Yuying Li, Mingzhu Meng, Junjie Hang, Haifeng Shi. A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapy. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02902-4
|
5 |
Hang He, Cai-Feng Zou, Yong-Jian Jiang, Feng Yang, Yang Di, Ji Li, Chen Jin, De-Liang Fu. Recurrence scoring system predicting early recurrence for patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy and portomesenteric vein resection. World Journal of Gastrointestinal Surgery 2024; 16(10): 3185-3201 doi: 10.4240/wjgs.v16.i10.3185
Abstract(110) |
Core Tip(115) |
Full Article(HTML)(607)
|
Full Article with Cover (PDF)-4889K(20)
|
Audio-371K(2)
|
Peer-Review Report-236K(18)
|
Answering Reviewers-552K(18)
|
Supplementary Material-476K(16)
|
Full Article (PDF)-4434K(20)
|
Full Article (XML)-181K(20)
|
Times Cited (0)
|
Total Visits (1386)
|
Open
|
6 |
Barbara Wlodarczyk, Lukasz Durko, Przemyslaw Wlodarczyk, Renata Talar-Wojnarowska, Ewa Malecka-Wojciesko. CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation. Journal of Clinical Medicine 2023; 12(12): 4050 doi: 10.3390/jcm12124050
|
7 |
Hye Yeon Chon, Hee Seung Lee, You-Na Sung, Yoo Keung Tae, Chan Hee Park, Galam Leem, So Jung Kim, Jung Hyun Jo, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Seung-Mo Hong, Seungmin Bang. Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-52909-4
|
8 |
Edin Hodžić, Sadat Pušina, Adi Mulabdić, Mirhan Salibašić, Emsad Halilović, Mujo Kadrić. Prognostic relevance of preoperative CA 19-9 values in stage III rectal adenocarcinoma: retrospective analysis and clinical implications. Medicinski Glasnik 2024; 21(2): 362 doi: 10.17392/1701-21-02
|
9 |
Hang He, Cai-Feng Zou, Feng Yang, Yang Di, Chen Jin, De-Liang Fu. Postoperative serum tumor markers-based nomogram predicting early recurrence for patients undergoing radical resections of pancreatic ductal adenocarcinoma. World Journal of Gastrointestinal Surgery 2024; 16(10): 3211-3223 doi: 10.4240/wjgs.v16.i10.3211
|